Highlightll Pharmaceutical (USA) LLC
1 clinical trials · Sponsor
◉ Watch Highlightll Pharmaceutical (USA) LLC
| Record | Firm | Date |
|---|---|---|
| First-in-Human Single and Multiple Dose of HL-400 (NCT06997484) | Highlightll Pharmaceutical (USA) LLC | 2025-04-25 |
Track Highlightll Pharmaceutical (USA) LLC automatically
Every clearance here is in the API, with alerts when new ones post.